Recce Pharmaceuticals LTD

Pharmaceutical Company - Anti-infectives

Based in DC

🤖

AI Overview

With $180K in lobbying spend across 10 quarterly filings, Recce Pharmaceuticals LTD is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2023 to 2025.

$180K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$20K
2024$80K
2025$80K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, Health Issues, Veterans

  • Healthcare, Anti-Infectives, PAHPA, Pasteur
  • Pandemic All Hazards Preparedness Act, S.3678 Pasteur Act, H.R.3932
  • Anti-Infectives Legislation National Defense Authorization Act of 2024, S.2226
  • Anti-Infectives Legislation

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.